ORTHO-EST Drug Patent Profile
✉ Email this page to a colleague
When do Ortho-est patents expire, and what generic alternatives are available?
Ortho-est is a drug marketed by Sun Pharm Inds Inc and is included in two NDAs.
The generic ingredient in ORTHO-EST is estropipate. There are two drug master file entries for this compound. Additional details are available on the estropipate profile page.
Summary for ORTHO-EST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Patent Applications: | 2,766 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORTHO-EST at DailyMed |
US Patents and Regulatory Information for ORTHO-EST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | ORTHO-EST | estropipate | TABLET;ORAL | 089567-001 | Feb 27, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Inds Inc | ORTHO-EST | estropipate | TABLET;ORAL | 089582-001 | Jul 17, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |